|
|
Volumn 3, Issue 1, 2004, Pages 9-10
|
|
Lysosomal storage diseases market
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGALSIDASE ALFA;
AGALSIDASE BETA;
ALGLUCERASE;
ALPHA GLUCOSIDASE;
ARYLSULFATASE;
BETA N ACETYLHEXOSAMINIDASE;
GALSULFASE;
GENZ 112638;
GENZ 99067;
GLUCOSYLCERAMIDASE;
IDURONATE 2 SULFATASE;
IMIGLUCERASE;
LARONIDASE;
LEVO IDURONIDASE;
MIGLUSTAT;
RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;
SPHINGOMYELIN PHOSPHODIESTERASE;
UNCLASSIFIED DRUG;
DRUG APPROVAL;
DRUG MARKETING;
ENZYME REPLACEMENT;
FABRY DISEASE;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
GLYCOGEN STORAGE DISEASE TYPE 2;
HUMAN;
HUNTER SYNDROME;
LYSOSOME STORAGE DISEASE;
MAROTEAUX LAMY SYNDROME;
MUCOPOLYSACCHARIDOSIS;
NIEMANN PICK DISEASE;
NOTE;
PRIORITY JOURNAL;
SANDHOFF DISEASE;
TAY SACHS DISEASE;
|
|
EID: 0347135830
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1286 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
